Union Minister of State for Health Bharati Pawar said on Friday that the World Health Organisation (WHO) is expected to grant the emergency use authorisation (EUA) to Covaxin soon.
The Strategic Advisory Group of Experts on Immunization (SAGE) will likely meet at the WHO on 5 October to discuss granting the EUA to Covaxin.
The SAGE is charged with advising WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions.
Earlier, the WHO had sought clarification on the data submitted by the Hyderabad – based vaccine manufacturer. The 5 October meeting has been called after Bharat Biotech provided all the details.
Meanwhile, Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella, said Covaxin production would touch 55 million doses in October as against 35 million in September.